Alerts will be sent to your verified email
Verify EmailSHRYDUS
|
Shrydus Industries
|
Prism Medico
|
Scintilla Commercial
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.6 % | -0.38 % | -4.19 % |
|
5yr average Equity Multiplier
|
2.48 | 1.24 | 1.19 |
|
5yr Average Asset Turnover Ratio
|
0.9 | 0.91 | 0.04 |
|
5yr Avg Net Profit Margin
|
9.84 % | -2.51 % | -69.31 % |
|
Price to Book
|
0.22 | 0.73 | 1.11 |
|
P/E
|
2.34 | 18.2 | 29.09 |
|
5yr Avg Cash Conversion Cycle
|
88.96 Days | 6011.61 Days | 129.63 Days |
|
Inventory Days
|
11.84 Days | 1005.44 Days | 0.0 |
|
Days Receivable
|
69.35 Days | 2100.76 Days | 129.63 Days |
|
Days Payable
|
36.97 Days | 20.88 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
686.2 | -7.97 | 60.34 |
|
5yr Avg ROCE
|
9.05 % | 0.36 % | 0.17 % |
|
5yr Avg Operating Profit Margin
|
9.73 % | -2.43 % | -10.74 % |
|
5 yr average Debt to Equity
|
0.93 | 0.12 | 0.04 |
|
5yr CAGR Net Profit
|
n/a | -25.65 % | n/a |
|
5yr Average Return on Assets
|
7.92 % | -0.31 % | -3.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
25.86 % | 25.0 % | 18.81 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.83 % | 1.07 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shrydus Industries
|
Prism Medico
|
Scintilla Commercial
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|